PROBLEM TO BE SOLVED: To provide a new carrier cell excellent in stability and safety, and is also capable of intraperitoneal administration and systemic administration or the like, for example, in gene therapy for cancer.SOLUTION: A carrier cell of the present invention is a new cell specified by receipt number of NITE AP-01818, and a gene therapy medicine for cancer of the present invention includes the new cell of the present invention as a carrier cell for allowing oncolytic virus to work on a tumor cell. An inducing method of an antitumor effect of the present invention can be performed by using the gene therapy medicine for cancer, and includes a process of administering a virus-infected carrier cell obtained by making the carrier cell to be infected with oncolytic virus, to a patient.
展开▼